New research from the Arnold School’s Department of Epidemiology and Biostatistics has found disparities in mortality rates and life expectancy for Americans living with sickle cell disease or cystic ...
The study will compare NHS and social data to track long term impact of childhood blood disorders.
NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results